00:13 , May 30, 2013 |  BC Extra  |  Politics & Policy

Brazil foundation awards $370M for research centers

The Sao Paulo Research Foundation (FAPESP) said it will provide $370 million over an 11-year period to 17 Brazilian Research, Innovation and Dissemination Centers (RIDCs). The centers must "actively seek out opportunities to contribute to...
07:00 , Aug 22, 2011 |  BC Week In Review  |  Company News

Becton Dickinson, Biodiversity deal

The companies partnered to develop and commercialize a portfolio of tests to detect infections using Becton Dickinson's BD MAX System for immunocompromised transplant patients. Molecular diagnostics company Biodiversity will be mostly responsible for development, while...
08:00 , Oct 30, 2006 |  BC Week In Review  |  Company News

LibraGen Inc., sanofi-aventis deal

Under a two-phase deal, SAN will use LibraGen's microbial biodiversity technology to discover compounds derived from non-cultivable microorganisms to treat infectious diseases and cancer. LibraGen will initially provide laboratory-extracted samples of these microorganisms to SAN,...
08:00 , Nov 10, 2004 |  BC Extra  |  Politics & Policy

NAFTA group backs Mexican GMO freeze

Mexican restrictions on planting transgenic corn should be maintained and strengthened, according to the Commission for Environmental Cooperation, an environmental group established under the North American Free Trade Agreement. The CEC said gene flow from...
07:00 , Sep 20, 2004 |  BioCentury  |  Emerging Company Profile

Evolva: Swiss Watchmaker

The chemistry bottleneck in drug discovery is defined by the time and cost required to identify and synthesize new compounds. Evolva Ltd. says its Watchmaker yeast-based technology helps it discover compounds faster than traditional high...
08:00 , Mar 5, 2004 |  BC Extra  |  Top Story

U.K. releases anti-GMO report

The U.K. Parliament's Environmental Audit Committee today published a report examining the design and operation of the farm-scale evaluations (FSEs) of genetically modified forage maize, beet, and oilseed rape. According to the committee's recommendations, no...
07:00 , Oct 20, 2003 |  BioCentury  |  Politics, Policy & Law

GMOs: Missing the nuance

A series of U.K. government-sponsored studies published last week showed that it's not possible to make broad generalizations about how genetic modification of crops affects levels of weed and insect levels in fields. They also...
07:00 , Jul 22, 2003 |  BC Extra  |  Politics & Policy

U.K. releases GM report

The U.K. government's GM Science Review Panel published its report on the potential use of genetically modified (GM) crops in the U.K. The panel concluded that risks to human health from GM crops on the...
07:00 , Jun 10, 2002 |  BC Week In Review  |  Company News

Diversa, University of Hawaii-Manoa deal

DVSA signed a biodiversity access and research collaboration agreement with the university's Marine Bioproducts Engineering Center (MarBEC). DVSA has the right to discover and commercialize products from genes from the existing material collections and environmental...
07:00 , Jun 3, 2002 |  BioCentury  |  Emerging Company Profile

Entomed: Drugs from bugs

Insects may provide a rich source of novel peptide and small molecule chemistry, but they have been untapped because little has been known about their immune systems. Entomed SA is taking advantage of work done...